Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries

J Am Acad Dermatol.

Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Takeshita J, French LE, Thiers BH, Hruza GJ, Fox LP, American Academy of Dermatology Ad Hoc Task Force on Covid-19.

doi: 10.1016/j.jaad.2020.05.109.

Further Publications Dermatology

Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic

JAMA Dermatol

Hubiche T, Cardot-Leccia N, Le Duff F, Seitz-Polski B, Giordana P, Chiaverini C, Giordanengo V, Gonfrier G, Raimondi V, Bausset O, Adjtoutah Z, Garnier M, Burel-Vandenbos F, Dadone-Montaudié B, Fassbender V, Palladini A, Courjon J, Mondain V, Contenti J, Dellamonica J, Leftheriotis G, Passeron T

doi: 10.1001/jamadermatol.2020.4324

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Acral purpuric lesions (Erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic

J Eur Acad Dermatol Venereol.

García-Gil MF, García García M, Monte Serrano J, Prieto-Torres L, Ara-Martín M

doi: 10.1111/jdv.16644.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection

J Eur Acad Dermatol Venereol.

El Hachem M, Diociaiuti A, Concato C, Carsetti R, Carnevale C, Ciofi Degli Atti M, Giovannelli L, Latella E, Porzio O, Rossi S, Stracuzzi A, Zaffina S, Onetti Muda A, Zambruno G, Alaggio R

doi: 10.1111/jdv.16682.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey

Arthritis Care Res (Hoboken).

Sirotich E, Dillingham S, Grainger R, Hausmann JS, COVID-19 Global Rheumatology Alliance Steering Committee.

doi: 10.1002/acr.24257.

Psoriasis

Impact of the COVID-19 pandemic on children with psoriasis

Ann Dermatol Venereol

Beytout Q, Pepiot J, Maruani A, Devulder D, Aubert R, Beylot-Barry M, Amici JM, Jullien D, Mahé E, Association France Psoriasis., Research Group on Psoriasis of the French Society of Dermatology (GrPso)., Research Group of the French Society of Pediatric Dermatology (SFPD).

doi: 10.1016/j.annder.2021.01.005

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic

JAMA Dermatol.

Herman A, Peeters C, Verroken A, Tromme I, Tennstedt D, Marot L, Dachelet C, Gruson D, Hermans C, Baeck M

doi: 10.1001/jamadermatol.

Psoriasis

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 - Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments

J Am Acad Dermatol

Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V 3rd, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Gondo G, Heydon S, Koons S, Ritchlin CT

doi: 10.1016/j.jaad.2020.12.058

Atopic DermatitisPsoriasis

Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic

Br J Dermatol.

Mahil SK, Yiu ZZN, Mason KJ, Dand N, Coker B, Wall D, Fletcher G, Bosma A, Capon F, Iversen L, Langan SM, Di Meglio P, Musters A, Prieto-Merino D, Tsakok T, Warren RB, Flohr C, Spuls P, Griffiths CEM, Barker J, Irvine AD, Smith CH, Secure-AD, PsoPROTECT study groups.

doi: 10.1111/bjd.19161.

Related content

Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries

Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic

Acral purpuric lesions (Erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic

A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection

Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey

Impact of the COVID-19 pandemic on children with psoriasis

Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 - Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments

Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic